Breast Implant Informed Consent Should Include the Risk of Anaplastic Large Cell Lymphoma.

MLA

Clemens, Mark W., et al. “Breast Implant Informed Consent Should Include the Risk of Anaplastic Large Cell Lymphoma.” Plastic and Reconstructive Surgery, vol. 137, no. 4, Apr. 2016, pp. 1117–22. EBSCOhost, https://doi.org/10.1097/01.prs.0000481103.45976.b1.

APA

Clemens, M. W., Miranda, R. N., & Butler, C. E. (2016). Breast Implant Informed Consent Should Include the Risk of Anaplastic Large Cell Lymphoma. Plastic and Reconstructive Surgery, 137(4), 1117–1122. https://doi.org/10.1097/01.prs.0000481103.45976.b1

Chicago

Clemens, Mark W, Roberto N Miranda, and Charles E Butler. 2016. “Breast Implant Informed Consent Should Include the Risk of Anaplastic Large Cell Lymphoma.” Plastic and Reconstructive Surgery 137 (4): 1117–22. doi:10.1097/01.prs.0000481103.45976.b1.